Loading clinical trials...
Loading clinical trials...
This is a prospective, multicenter, non-interventional study to test the safety and effectiveness of MabThera administered subcutaneously in participants with NHL or CLL. The length of study is expect...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Hoffmann-La Roche
NCT02682667 · Multiple Myeloma, Lymphoma, Non-Hodgkin, and more
NCT01676805 · Hodgkin Disease, Lymphoma, Non-Hodgkin, and more
NCT06299540 · Leukemia, Lymphocytic, Chronic, B-Cell
NCT06923397 · Lymphoma, Lymphoma, Hodgkin, and more
NCT06510361 · Lymphoma, Follicular Lymphoma, and more
Soon Chun Hyang University Hospital Bucheon
Bucheon-si
Inje University Busan Paik Hospital
Busan
Pusan National University Hospital
Busan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions